Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.TrimGen, a molecular diagnostic company, has received the FDA 510(k) clearance to market its eQ-PCR LC warfarin genotyping kit.
Subscribe to our email newsletter
According to TrimGen, its eQ-PCR LC warfarin genotyping assay will be used as an aid in the identification of patients who may be at risk of warfarin sensitivity.
Howard Doong of TrimGen, said: “The FDA approval is an important milestone for TrimGen. It indicates that our eQ-PCR technology has met the regulatory challenges; our efforts warrant not only a simple, accurate diagnostic test but also the future commercial success of the company.”